REMINDER: Our user survey closes on Friday, please submit your responses here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I’d say 20.02 is a bit early to be hitting the bottle - or discussion boards.
If there is a BOD, they are FAST asleep!!!!!
Obviously, you are very happy , lots of reasons to be, not point to be upset, what good it will bring, wrote off this investment not selling and equally not adding more.
Do I get the impression that lofas is not happy?
Lofas you don’t know what is going on inside Scancell. There may be some very high level discussions going on that hinge on the quality of the trial data due in 3 to 4 months time,
The market is not the truth it’s just sentiment in a vacuum.
I hoped that at least one new deal would have been confirmed by now but I don’t know what is happening or if anyone is seriously evaluating either AvidiMab or one of our GlyMab’s.
It’s just guess work at best. I would like to believe that the trials are building solid data that cannot be ignored. I would hope that both our Mab platforms are being well received and proving they do what it says on the tin.
So as I said before it’s up to us to decide if we hold on or take a hit and move on.
I’m holding on because everything trial wise is so far, looking very positive.
Not adding any more even at 0.1p, abysmal company shameful management , hope for good results for patient all be it not from this poke in the eye company.
No I was not lucky enough to do that. I’m £18K down on this pos.
"Spoke to soon " Saturday , Its only Tuesday and they are indeed cheaper.
Under 9p today .
Oh the irony in your 18:46 Lofas.
@lofas - I take you sold up a while back and are looking for a cheaper buy in?
8 soon. Buying at 11P proved to be throwing good money after bad.
No posts as there is nothing to say. Better this way rather than trying to follow the pile of nonsense coming out from LTH.
The selling looks like patience has run out for some folk. It’s Scancell’s year end today so no last minute deals or trail news.
There is no quick route to the trial data, it will arrive as soon as enough patients have reached their scans and the results have been confirmed. What can happen at any time are ‘deals’. GenMab may even get the green light to start a trial with our GlyMab target tomorrow or in three months.
So it’s down to each investor do you stick or twist.
I’m sticking, solely because I believe that the data when it arrives will be worth every bit of the wait.
It certainly isn’t WTP….nothing but sells over the past few days, which suggests to me that news is some way off. Hope I’m wrong!
The similar lack of news/RNS's isn't helping the SP either it seems.
Stakis,
"No posts since Sunday - is the site down?"
It's a fair question. I thought my iPad had frozen so rebooted a couple of times. It must be a record for the length of time without a post on the LSE SCLP board.
As TF says, plenty on ADVFN/PoG so maybe everyone is catching up on the War and Peace plot over there.
Nope ! Have a look at PoG if you are bored. ATB
No posts since Sunday - is the site down?
WTP
Yes well liked and well respected
Excellent
Nice find. Brad Locar seems to be one of the most followed bio reporters does he not?
Good to see that Brad Loncar will be interviewing Lindy Durrant on his UK tour 'profiling the best of life sciences in London, Oxford, and Cambridge.'
https://twitter.com/BiotechTVHQ/status/1783797670462587120
I thought, would have at the vaccines we have pitched against in the other trials in the ASCO article find below
1.Evaxion Biotech 26th of April -4.1800
+0.0600 (+1.46%)
Day's Range 4.0500 - 4.2500
52 Week Range 2.8240 - 18.5000
https://www.evaxion-biotech.com
2. BioNtech https://www.biontech.com/int/en/home.html
Prev. Close 86.71
52 Wk. Low 85.21
52 Wk. High 125.83
3. Moderna https://www.modernatx.com/en-GB
Prev. Close 106.18
52 Wk. Low 62.55
52 Wk. High 142.79
4. Scancell https://www.scancell.co.uk
Prev. Close 9.60p
52 Wk. Low 7.59
52 Wk. High 18.29
5.IQ Biotech, Inc
https://iobiotech.com
Prev. Close 1.4500
52 Wk. Low 0.8160
52 Wk. High 2.6400
Sorry, last sentence should read "accountant"
Ripley,
Yes, in principle losses can be offset against gains as far as CGT liability goes,
There are a number of considerations though that can make the actual calculation complicated:
There are different rates of CGT for stocks and residential property. So offsetting one type against another will affect the tax liability.
There is CGT allowance and a personal tax allowance and both may come into play.
A capital gain is taxed when it is materialised so you can't offset paper losses!
Your account will be able to advise you on your particular circumstances.